Objective Measurement of Retinal Ischemia in Central Retinal Vein Occlusion, and the Effects of Treatment With a Vascular Endothelial Growth Factor Inhibitor.
Phase of Trial: Phase IV
Latest Information Update: 14 Dec 2015
At a glance
- Drugs Ranibizumab (Primary)
- Indications Central retinal vein occlusion
- Focus Therapeutic Use
- 14 Dec 2015 New trial record